Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women. / Rinaldi, Sabina; Dossus, Laure; Keski-Rahkonen, Pekka; Kiss, Agneta; Navionis, Anne-Sophie; Biessy, Carine; Travis, Ruth; Weiderpass, Elisabete; Romieu, Isabelle; Eriksen, Anne Kirstine; Tjonneland, Anne; Kvaskoff, Marina; Canonico, Marianne; Truong, Thérèse; Katzke, Verena; Kaaks, Rudolf; Catalano, Alberto; Panico, Salvatore; Masala, Giovanna; Tumino, Rosario; Lukic, Marko; Olsen, Karina Standahl; Zamora-Ros, Raul; Santiuste, Carmen; Aizpurua Atxega, Amaia; Guevara, Marcela; Rodriguez-Barranco, Miguel; Sandstrom, Maria; Hennings, Joakim; Almquist, Martin; Aglago Kouassivi, Elom; Christakoudi, Sofia; Gunter, Marc; Franceschi, Silvia.

In: International Journal of Cancer, Vol. 154, No. 12, 2024, p. 2064-2074.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rinaldi, S, Dossus, L, Keski-Rahkonen, P, Kiss, A, Navionis, A-S, Biessy, C, Travis, R, Weiderpass, E, Romieu, I, Eriksen, AK, Tjonneland, A, Kvaskoff, M, Canonico, M, Truong, T, Katzke, V, Kaaks, R, Catalano, A, Panico, S, Masala, G, Tumino, R, Lukic, M, Olsen, KS, Zamora-Ros, R, Santiuste, C, Aizpurua Atxega, A, Guevara, M, Rodriguez-Barranco, M, Sandstrom, M, Hennings, J, Almquist, M, Aglago Kouassivi, E, Christakoudi, S, Gunter, M & Franceschi, S 2024, 'Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women', International Journal of Cancer, vol. 154, no. 12, pp. 2064-2074. https://doi.org/10.1002/ijc.34872

APA

Rinaldi, S., Dossus, L., Keski-Rahkonen, P., Kiss, A., Navionis, A-S., Biessy, C., Travis, R., Weiderpass, E., Romieu, I., Eriksen, A. K., Tjonneland, A., Kvaskoff, M., Canonico, M., Truong, T., Katzke, V., Kaaks, R., Catalano, A., Panico, S., Masala, G., ... Franceschi, S. (2024). Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women. International Journal of Cancer, 154(12), 2064-2074. https://doi.org/10.1002/ijc.34872

Vancouver

Rinaldi S, Dossus L, Keski-Rahkonen P, Kiss A, Navionis A-S, Biessy C et al. Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women. International Journal of Cancer. 2024;154(12):2064-2074. https://doi.org/10.1002/ijc.34872

Author

Rinaldi, Sabina ; Dossus, Laure ; Keski-Rahkonen, Pekka ; Kiss, Agneta ; Navionis, Anne-Sophie ; Biessy, Carine ; Travis, Ruth ; Weiderpass, Elisabete ; Romieu, Isabelle ; Eriksen, Anne Kirstine ; Tjonneland, Anne ; Kvaskoff, Marina ; Canonico, Marianne ; Truong, Thérèse ; Katzke, Verena ; Kaaks, Rudolf ; Catalano, Alberto ; Panico, Salvatore ; Masala, Giovanna ; Tumino, Rosario ; Lukic, Marko ; Olsen, Karina Standahl ; Zamora-Ros, Raul ; Santiuste, Carmen ; Aizpurua Atxega, Amaia ; Guevara, Marcela ; Rodriguez-Barranco, Miguel ; Sandstrom, Maria ; Hennings, Joakim ; Almquist, Martin ; Aglago Kouassivi, Elom ; Christakoudi, Sofia ; Gunter, Marc ; Franceschi, Silvia. / Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women. In: International Journal of Cancer. 2024 ; Vol. 154, No. 12. pp. 2064-2074.

Bibtex

@article{5ecd8753016d45059c554863192b7390,
title = "Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women",
abstract = "Thyroid cancer (TC) is substantially more common in women than in men, pointing to a possible role of sex steroid hormones. We investigated the association between circulating sex steroid hormones, sex hormone binding globulin (SHBG) and the risk of differentiated TC in men and women within the European Prospective Investigation into Cancer and nutrition (EPIC) cohort. During follow-up, we identified 333 first primary incident cases of differentiated TC (152 in pre/peri-menopausal women, 111 in post-menopausal women, and 70 in men) and 706 cancer-free controls. Women taking exogenous hormones at blood donation were excluded. Plasma concentrations of testosterone, androstenedione, dehydroepiandrosterone, estradiol, estrone and progesterone (in pre-menopausal women only) were performed using liquid chromatography/mass spectrometry method. SHBG concentrations were measured by immunoassay. Odds ratios (ORs) were estimated using conditional logistic regression models adjusted for possible confounders. No significant associations were observed in men and postmenopausal women, while a borderline significant increase in differentiated TC risk was observed with increasing testosterone (adjusted OR T3 vs T1: 1.68, 95% CI: 0.96-2.92, ptrend  = .06) and androstenedione concentrations in pre/perimenopausal women (adjusted OR T3 vs T1: 1.78, 95% CI: 0.96-3.30, ptrend  = .06, respectively). A borderline decrease in risk was observed for the highest progesterone/estradiol ratio (adjusted OR T3 vs T1: 0.54, 95% CI: 0.28-1.05, ptrend  = .07). Overall, our results do not support a major role of circulating sex steroids in the etiology of differentiated TC in post-menopausal women and men but may suggest an involvement of altered sex steroid production in pre-menopausal women.",
author = "Sabina Rinaldi and Laure Dossus and Pekka Keski-Rahkonen and Agneta Kiss and Anne-Sophie Navionis and Carine Biessy and Ruth Travis and Elisabete Weiderpass and Isabelle Romieu and Eriksen, {Anne Kirstine} and Anne Tjonneland and Marina Kvaskoff and Marianne Canonico and Th{\'e}r{\`e}se Truong and Verena Katzke and Rudolf Kaaks and Alberto Catalano and Salvatore Panico and Giovanna Masala and Rosario Tumino and Marko Lukic and Olsen, {Karina Standahl} and Raul Zamora-Ros and Carmen Santiuste and {Aizpurua Atxega}, Amaia and Marcela Guevara and Miguel Rodriguez-Barranco and Maria Sandstrom and Joakim Hennings and Martin Almquist and {Aglago Kouassivi}, Elom and Sofia Christakoudi and Marc Gunter and Silvia Franceschi",
note = "{\textcopyright} 2024 The World Health Organization. The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.",
year = "2024",
doi = "10.1002/ijc.34872",
language = "English",
volume = "154",
pages = "2064--2074",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley",
number = "12",

}

RIS

TY - JOUR

T1 - Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women

AU - Rinaldi, Sabina

AU - Dossus, Laure

AU - Keski-Rahkonen, Pekka

AU - Kiss, Agneta

AU - Navionis, Anne-Sophie

AU - Biessy, Carine

AU - Travis, Ruth

AU - Weiderpass, Elisabete

AU - Romieu, Isabelle

AU - Eriksen, Anne Kirstine

AU - Tjonneland, Anne

AU - Kvaskoff, Marina

AU - Canonico, Marianne

AU - Truong, Thérèse

AU - Katzke, Verena

AU - Kaaks, Rudolf

AU - Catalano, Alberto

AU - Panico, Salvatore

AU - Masala, Giovanna

AU - Tumino, Rosario

AU - Lukic, Marko

AU - Olsen, Karina Standahl

AU - Zamora-Ros, Raul

AU - Santiuste, Carmen

AU - Aizpurua Atxega, Amaia

AU - Guevara, Marcela

AU - Rodriguez-Barranco, Miguel

AU - Sandstrom, Maria

AU - Hennings, Joakim

AU - Almquist, Martin

AU - Aglago Kouassivi, Elom

AU - Christakoudi, Sofia

AU - Gunter, Marc

AU - Franceschi, Silvia

N1 - © 2024 The World Health Organization. The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.

PY - 2024

Y1 - 2024

N2 - Thyroid cancer (TC) is substantially more common in women than in men, pointing to a possible role of sex steroid hormones. We investigated the association between circulating sex steroid hormones, sex hormone binding globulin (SHBG) and the risk of differentiated TC in men and women within the European Prospective Investigation into Cancer and nutrition (EPIC) cohort. During follow-up, we identified 333 first primary incident cases of differentiated TC (152 in pre/peri-menopausal women, 111 in post-menopausal women, and 70 in men) and 706 cancer-free controls. Women taking exogenous hormones at blood donation were excluded. Plasma concentrations of testosterone, androstenedione, dehydroepiandrosterone, estradiol, estrone and progesterone (in pre-menopausal women only) were performed using liquid chromatography/mass spectrometry method. SHBG concentrations were measured by immunoassay. Odds ratios (ORs) were estimated using conditional logistic regression models adjusted for possible confounders. No significant associations were observed in men and postmenopausal women, while a borderline significant increase in differentiated TC risk was observed with increasing testosterone (adjusted OR T3 vs T1: 1.68, 95% CI: 0.96-2.92, ptrend  = .06) and androstenedione concentrations in pre/perimenopausal women (adjusted OR T3 vs T1: 1.78, 95% CI: 0.96-3.30, ptrend  = .06, respectively). A borderline decrease in risk was observed for the highest progesterone/estradiol ratio (adjusted OR T3 vs T1: 0.54, 95% CI: 0.28-1.05, ptrend  = .07). Overall, our results do not support a major role of circulating sex steroids in the etiology of differentiated TC in post-menopausal women and men but may suggest an involvement of altered sex steroid production in pre-menopausal women.

AB - Thyroid cancer (TC) is substantially more common in women than in men, pointing to a possible role of sex steroid hormones. We investigated the association between circulating sex steroid hormones, sex hormone binding globulin (SHBG) and the risk of differentiated TC in men and women within the European Prospective Investigation into Cancer and nutrition (EPIC) cohort. During follow-up, we identified 333 first primary incident cases of differentiated TC (152 in pre/peri-menopausal women, 111 in post-menopausal women, and 70 in men) and 706 cancer-free controls. Women taking exogenous hormones at blood donation were excluded. Plasma concentrations of testosterone, androstenedione, dehydroepiandrosterone, estradiol, estrone and progesterone (in pre-menopausal women only) were performed using liquid chromatography/mass spectrometry method. SHBG concentrations were measured by immunoassay. Odds ratios (ORs) were estimated using conditional logistic regression models adjusted for possible confounders. No significant associations were observed in men and postmenopausal women, while a borderline significant increase in differentiated TC risk was observed with increasing testosterone (adjusted OR T3 vs T1: 1.68, 95% CI: 0.96-2.92, ptrend  = .06) and androstenedione concentrations in pre/perimenopausal women (adjusted OR T3 vs T1: 1.78, 95% CI: 0.96-3.30, ptrend  = .06, respectively). A borderline decrease in risk was observed for the highest progesterone/estradiol ratio (adjusted OR T3 vs T1: 0.54, 95% CI: 0.28-1.05, ptrend  = .07). Overall, our results do not support a major role of circulating sex steroids in the etiology of differentiated TC in post-menopausal women and men but may suggest an involvement of altered sex steroid production in pre-menopausal women.

U2 - 10.1002/ijc.34872

DO - 10.1002/ijc.34872

M3 - Journal article

C2 - 38357914

VL - 154

SP - 2064

EP - 2074

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 12

ER -

ID: 383387526